SAFETY DATA SHEET

Creation Date 04-Oct-2012 Revision Date 04-Oct-2012 Revision Number 2

SECTION 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE

COMPANY/UNDERTAKING

Product Identifier
Product Description: Salmonella H g,s,t Agglutinating Sera
Cat No. R30161501

Relevant identified uses of the substance or mixture and uses advised against
Recommended Use In vitro diagnostic.
Uses advised against No Information available

Details of the supplier of the safety data sheet

Company Supplier
REMEL (EUROPE) LIMITED Oxoid Ltd.
Remel House Wade Road
Clipper Boulevard West Basingstoke, Hants, UK
Crossways, Dartford RG24 8PW
Kent. DA2 6PT Telephone: +44 (0) 1256 841144
UK
Tel: (+44) 1322 295600
Fax: (+44) 1322 225413
mbd-sds@thermofisher.com
E-mail address mbd-sds@thermofisher.com

Emergency Telephone Number

Carechem 24: +44 (0) 1865 407333

SECTION 2. HAZARDS IDENTIFICATION

Classification of the substance or mixture

REGULATION (EC) No 1272/2008
Not hazardous

Classification according to EU Directives 67/548/EEC or 1999/45/EC

For the full text of the R-phrases and H-Statements mentioned in this Section, see Section 16
R-phrase(s) R22 - Harmful if swallowed

Label Elements

Signal Word None

Other Hazards

OXDR30161501
Page 1/9
________________________SECTION 2. HAZARDS IDENTIFICATION
No information available.
Component EC-No. Weight % CAS-No 67/548/EEC SAFETY
CLP DATA SHEET
REACH No.
Classification Classification
-
Regulation
Sodium hydroxide EEC No. 215- <0.5 1310-73-2 C; R35 Skin(EC)
Corr. 1A 01-2119457892-27
1310-73-2 185-5 (H314)
Eye Dam. 1
(H318)
Sodium azide
Salmonella EEC No. Sera
H g,s,t Agglutinating 247- 0.1 26628-22-8 T+; R28 Acute Tox. Revision
2 Date 04-Oct-2012
26628-22-8 852-1 R32 (H300)
N; R50-53 Aquatic Acute
1
(H400)
Aquatic
Chronic 1
Description of first aid measures (H410)
Rinse thoroughly with plenty of water, also under the eyelids. Obtain medical
Eye Contact SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS
attention.
Skin Contact Obtain medical attention. Wash off with warm water and soap.

Ingestion Do not induce vomiting. Get medical attention.

Inhalation Move to fresh air. Obtain medical attention.

For the full text of the R-

phrases and H-Statements
mentioned in this Section,
see Section 16
SECTION 4. FIRST AID MEASURES

Notes to Physician Treat symptomatically

SECTION 5. FIRE-FIGHTING MEASURES

Extinguishing media

Suitable Extinguishing Media

Use extinguishing measures that are appropriate to local circumstances and the surrounding environment

Extinguishing media which must not be used for safety reasons

No information available.

OXDR30161501
Page 2/9
Special hazards arising from the substance or mixture

Thermal decomposition can lead to release of irritating gases and vapors

SAFETY DATA SHEET
Advice for fire-fighters

As in any fire, wear self-contained breathing apparatus pressure-demand, MSHA/NIOSH (approved or equivalent) and full protective
gear

SECTION 6. ACCIDENTAL RELEASE MEASURES

Personal precautions,
Salmonella protective
H g,s,t equipment
Agglutinating Seraand emergency procedures Revision Date 04-Oct-2012
Use personal protective equipment. Ensure adequate ventilation. Do not get in eyes, on skin, or on clothing.

Environmental precautions

Prevent further leakage or spillage if safe to do so. Prevent product from entering drains.

Methods and material for containment and cleaning up

Soak up with inert absorbent material. Clean contaminated surface thoroughly.

SECTION 7. HANDLING AND STORAGE

Precautions for Safe Handling

Do not get in eyes, on skin, or on clothing. Wear personal protective equipment. Use only in well-ventilated areas.

Conditions for safe storage, including any incompatibilities

Keep container tightly closed. Keep at temperatures between 2° and 8 °C.

Specific End Uses

SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION

European Union The United France Belgium Spain
Kingdom
2 mg/m 3
STEL VME: 2 mg/m3 8 2 mg/m3 VLE VLA-EC: 2 mg/m3 15
heures. minutos
Skin Skin VME: 0.1 mg/m3 8 Skin Skin
TWA 0.1 mg/m3 TWA 0.1 mg/m3 heures. restrictive TWA 0.1 mg/m3 VLA-EC: 0.3 mg/m3
STEL 0.3 mg/m3 STEL 0.3 mg/m3 limit STEL 0.3 mg/m3 15
VLCT: 0.3 mg/m3 minutos
Skin VLA-ED: 0.1 mg/m3
8

Control parameters

Exposure limits
Component
Sodium hydroxide
Sodium azide

OXDR30161501
Page 3/9
 Italy Germany Portugal The Netherlands Finland
2 mg/m3 TWA Ceiling: 2 mg/m3 STEL: 2 mg/m3 15
(inhalable fraction) SAFETY
minuutteina
Ceiling: 2 mg/m3

ore.
3
TWA: 0.1 mg/m 8 MAK 0.2 mg/m
(inhalable)
3
Ceiling: 0.29
mg/m3
Skin
STEL: 0.3 mg/m3 15
DATA
TWA: 0.1 mg/m3 8
tunteina
STEL: 0.3 mg/m3 15
minuti.
Ceiling: 0.11 ppm minuten
TWA: 0.1 mg/m3 8
SHEET
STEL: 0.3 mg/m3 15
minuutteina
Skin uren Skin
Austria Denmark Switzerland Poland Norway
STEL: 4 mg/m 3
15 Ceiling: 2 mg/m3 STEL: 2 mg/m3 15 NDSCh: 1 mg/m3 15 Ceiling: 2 mg/m3
Salmonella H Revision Date 04-
Minuten Minuten minutach
g,s,t2 mg/m3 8 Oct-2012
TWA: MAK: 2 mg/m3 8 TWA: 0.5 mg/m3 8
Agglutinating
Stunden Stunden godzinach
Sera
Component
Skin TWA: 0.1 mg/m3 8 STEL: 0.4 mg/m3 15 NDSCh: 0.3 mg/m3 Skin
3
STEL: 0.3 mg/m 15
Sodium hydroxide timer Minuten 15 Ceiling: 0.3 mg/m3
Minuten Skin MAK: 0.2 mg/m3 8 minutach
TWA: 0.1 mg/m3 8 Stunden TWA: 0.1 mg/m3 8
Stunden
Sodium azide godzinach
Bulgaria Croatia Ireland Skóra
Cyprus Czech Republic
TWA: 2.0 mg/m3 STEL: 2 mg/m3 15 STEL: 2 mg/m3 15 TWA: 1 mg/m3 8
minutama. min hodinách.
Ceiling: 2 mg/m3
TWA: 0.1 mg/m3 Skin Notation TWA: 0.1 mg/m3 8 Skin-potential for TWA: 0.1 mg/m3 8
STEL : 0.3 mg/m3 TWA: 0.2 mg/m3 8 hr. cutaneous hodinách.
Component
Skin notation satima. NaN3 absorption Potential for
Sodium hydroxideSTEL: 0.3 mg/m3 15 STEL: 0.3 mg/m3 15 STEL: 0.3 mg/m3 cutaneous
minutama. min TWA: 0.1 mg/m3 absorption
Estonia Gibraltar Skin
Greece Hungary Ceiling: 0.3 mg/m3
Iceland
TWA: 1 mg/m3 8 STEL: 2 mg/m3 STEL: 2 mg/m3 15 STEL: 2 mg/m3
Sodium azide
tundides. TWA: 2 mg/m3 percekben.
TWA: 2 mg/m3 8
órában.
Skin notation Skin notation STEL: 0.1 ppm STEL: 0.3 mg/m3 15 STEL: 0.3 mg/m3
TWA: 0.1 mg/m3 8 TWA: 0.1 mg/m3 8 hr STEL: 0.3 mg/m3 percekben. TWA: 0.1 mg/m3 8
tundides. STEL: 0.3 mg/m3 15 TWA: 0.1 ppm TWA: 0.1 mg/m3 8 klukkustundum.
Component
STEL: 0.3 mg/m3 15 min TWA: 0.3 mg/m3 órában. Skin notation
minutites.
Sodium hydroxide Ceiling: 0.2 mg/m3
Latvia Lithuania Luxembourg Malta Romania
TWA: 0.5 mg/m3 Ceiling: 2 mg/m3
Sodium
skin azide
- potential for TWA: 0.1 mg/m3 possibility of Skin notation
cutaneous exposure Skin notation significant TWA: 0.1 mg/m3 8
STEL: 0.3 mg/m3 STEL: 0.3 mg/m3 uptake through the ore
TWA: 0.1 mg/m3 skin STEL: 0.3 img/m3 15
TWA: 0.1 mg/m3 minute
STEL: 0.3 mg/m3 15
Component
Sodium hydroxide

Sodium azide

Component
Sodium hydroxide
Sodium azide

OXDR30161501
Page 4/9
Russia - TWA Slovak Republic Slovenia Sweden Turkey
TWA: 2 mg/m3 TWA: 2 mg/m3 8 LLV: 1 mg/m3 8
urah
inhalable fraction
timmar.
inhalable dust
SAFETY
STEL: 2 mg/m3 15
minutah inhalable
CLV: 2 mg/m3 DATA
Ceiling: 0.3 mg/m3
TWA' 0.1 mg/m3
TWA:fraction
0.1 mg/m3 8
urah
STV: 0.3 mg/m3 15
minuter
SHEET
Skin notation
TWA: 0.1 mg/m 83

Potential for LLV: 0.1 mg/m3 8 saat

cutaneous timmar. STEL: 0.3 mg/m3 15
absorption Skin notation dakika
Salmonella H STEL: 0.3 mg/m3 15 Revision Date 04-
g,s,t Oct-2012
Agglutinating
Sera
Component
Sodium hydroxide

Sodium azide

Biological limit values
Derived No Effect Level (DNEL)
Predicted No Effect Concentration
(PNEC)
This product, as supplied, does not contain any hazardous materials with biological limits
established by the region specific regulatory bodies.
No information available.
No information available.

Exposure controls

Engineering Measures Ensure adequate ventilation, especially in confined areas

Personal protective equipment
Eye Protection
Hand Protection
Skin and body protection
Respiratory Protection
Safety glasses with side-shields
Protective gloves
Long sleeved clothing
When workers are facing concentrations above the exposure limit they must use appropriate
certified respirators

Hygiene Measures Handle in accordance with good industrial hygiene and safety practice
Environmental exposure controls Prevent product from entering drains

SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES

Physical State Liquid

Appearance Amber
pH 6.6 - 6.8
Boiling Point/Range Not applicable
Melting Point/Range Not applicable
Flash Point Not applicable
Autoignition Temperature Not applicable

SECTION 10. STABILITY AND REACTIVITY

Reactivity

Chemical Stability

OXDR30161501
Page 5/9
 Revision Date 04-Oct-2012

SAFETY DATA SHEET

Stable under recommended storage conditions.
Possibility of Hazardous Reactions

Hazardous Polymerization Hazardous polymerization does not occur.

Hazardous Reactions . None under normal processing..

Conditions to Avoid
Salmonella H g,s,t Agglutinating Sera
Extremes of temperature and direct sunlight.

Incompatible Materials

Strong oxidizing agents, Acids.

Hazardous Decomposition Products

None under normal use conditions.

SECTION 11. TOXICOLOGICAL INFORMATION

LD50 Oral LD50 Dermal LC50 Inhalation (Dust)
1350 mg/kg ( Rabbit )
27 mg/kg ( Rat ) 20 mg/kg ( Rabbit )
50 iTig/kg ( Rat )

Information on Toxicological
Effects

Acute Toxicity
Product Information Product
does not
present
Component Information an acute
toxicity
Component hazard
Sodium hydroxide based on
Sodium azide known
informatio
n

Chronic Toxicity
Carcinogenicity There are no known carcinogenic chemicals in this product

Sensitization None known

Mutagenic Effects None known
Reproductive Effects None known
Developmental Effects None known
Target Organs None known.
Endocrine Disruptor Information None known

OXDR30161501
Page 6/9
 Component Freshwater Algae Freshwater Fish Microtox Water Flea
Sodium hydroxide 45.4 mg/L LC50 96 h
Sodium azide 0.8 mg/L LC50 96 h SAFETY
0.7 mg/L LC50 96 h
5.46 mg/L LC50 96 h DATA
SHEET

Salmonella H g,s,t Revision Date 04-Oct-

Agglutinating Sera 2012

SECTION 12. ECOLOGICAL INFORMATION

Toxicity
Ecotoxicity effects

Persistence and degradability

No information available
Bioaccumulative potential
No information available.
Mobility in soil
No information available.
Results of PBT and vPvB assessment
Other adverse effects
No information available

SECTION 13. DISPOSAL CONSIDERATIONS

Waste treatment methods

Waste from Residues / Unused Dispose of in accordance with local regulations

Products

Contaminated Packaging Empty containers should be taken to local recyclers for disposal

SECTION 14. TRANSPORT INFORMATION

IMDG/IMO Not regulated

ADR Not regulated

IATA Not regulated

OXDR30161501
Page 7/9
 Component EINEC ELINC NLP TSCA DSL NDSL PICCS ENCS CHINA AICS KECL
Sodium hydroxide S
215- S- X X - X X X X X
Sodium azide 185-5
247-
852-1
X X X SAFETY DATA
X X X X

SHEET

Salmonella H g,s,t Revision Date 04-Oct-2012

Agglutinating Sera

SECTION 15. REGULATORY INFORMATION

Safety, health and environmental regulations/legislation specific for the substance or mixture

Take note of Directive 98/24/EC on the protection of the health and safety of workers from the risks related to chemical agents at work

International Inventories

Legend

TSCA - United States Toxic Substances Control Act Section 8(b) Inventory
EINECS/ELINCS - European Inventory of Existing Commercial Chemical Substances/EU List of Notified Chemical
Substances
DSL/NDSL - Canadian Domestic Substances List/Non-Domestic Substances List
PICCS - Philippines Inventory of Chemicals and Chemical Substances
ENCS - Japan Existing and New Chemical Substances
CHINA - China Inventory of Existing Chemical Substances
AICS - Inventory of Chemical Substances
KECL - Existing and Evaluated Chemical Substances

Chemical Safety Assessment

SECTION 16. OTHER INFORMATION

Full text of R-phrases referred to under sections 2 and 3

R22 - Harmful if swallowed
R28 - Very toxic if swallowed
R32 - Contact with acids liberates very toxic gas
R35 - Causes severe burns
R50/53 - Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment

Full text of H-Statements referred to under sections 2 and 3

H300 - Fatal if swallowed
H400 - Very toxic to aquatic life
H410 - Very toxic to aquatic life with long lasting effects
EUH032 - Contact with acids liberates very toxic gas.
H314 - Causes severe skin burns and eye damage
H318 - Causes serious eye damage

OXDR30161501
Page 8/9
 SECTION 16. OTHER INFORMATION_________________________
Prepared By Regulatory Affairs
Revision Date 04-Oct-2012 SAFETY DATA SHEET
Revision Summary
Reason for revision Change to composition.
This safety data sheet complies with the requirements of Regulation (EC) No. 1907/2006
Disclaimer
The information provided on this Safety Data Sheet is correct to the best of our knowledge, information and belief at the date
of its publication. The information given is designed only as a guide for safe handling, use, processing, storage,
transportation,
Salmonelladisposal
H g,s,t and release andSera
Agglutinating is not to be considered as a warranty or quality specification. The information
Revision Date 04-Oct-2012
relates only to the specific material designated and may not be valid for such material used in combination with any other
material or in any process, unless specified in the text.

End of Safety Data Sheet

OXDR30161501
Page 9/9